Related Experiment Video
Updated: Jul 7, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Functional blockade of Smad4 leads to a decrease in beta-catenin levels and signaling activity in human pancreatic
Diana Romero1, Maite Iglesias, Calvin P H Vary
1Instituto de Investigaciones Biomedicas Alberto Sols, Arturo Duperier 4, 28029 Madrid, Spain. romerd@mmc.org
Carcinogenesis
|March 4, 2008
Summary
Smad4 inactivation in pancreatic cancer cells disrupts beta-catenin stability, reducing tumor growth. This suggests Smad4 acts independently of TGF-beta signaling to regulate beta-catenin, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor beta (TGF-beta) signaling involves Smad proteins, but also activates Smad-independent pathways.
- Loss-of-function mutations in Smad4 occur frequently in human pancreatic cancer.
- Previous research indicated a link between oncogenic Ras and Smad4 inactivation in malignant progression.
Purpose of the Study:
- To investigate the function of Smad4 in human pancreatic cancer.
- To explore the relationship between Smad4 and beta-catenin signaling in pancreatic adenocarcinoma cells.
Main Methods:
- Expression of a dominant-negative Smad4 construct in PANC-1 cells.
- Analysis of beta-catenin ubiquitination and proteasomal degradation.
- Assessment of beta-catenin signaling activity.
- Evaluation of tumor growth in scid mice.
Main Results:
- Smad4 loss increased beta-catenin ubiquitination and proteasomal degradation.
- Loss of Smad4 abrogated beta-catenin signaling activity.
- Smad4 inactivation reduced the tumorigenic potential of PANC-1 cells.
- These effects were independent of the TGF-beta/Smad2,3 signaling pathway.
Conclusions:
- Smad4 interacts with the Wnt/beta-catenin pathway in pancreatic cancer cells.
- Smad4 functions as an attenuator of beta-catenin proteasomal degradation.
- This cross-talk presents a novel role for Smad4 in pancreatic carcinoma progression.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...